MedTrace Logo

Optimization of Drug Treatment in Hospitalized Elderly (OMAGE)

NCT00450034 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 665

Last updated 2011-12-01

No results posted yet for this study

Summary

A randomized trial has been designed to determine if this complex intervention can significantly decrease the risk of unplanned readmissions in this very elderly population, compared with usual care.

Conditions

  • Global Medical Assessment of Elderly Frail Patients

Interventions

PROCEDURE

drug - oriented multifaceted intervention

oriented multifaceted intervention

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Sylvie LEGRAIN, MD,PhD · Assistance Publique - Hôpitaux de Paris

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-06-30
Completion
2009-06-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00450034 on ClinicalTrials.gov